Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS · Delayed Price · Currency is USD
0.6100
-0.0040 (-0.65%)
Jul 24, 2025, 4:00 PM EDT

Medicenna Therapeutics Statistics

Total Valuation

MDNAF has a market cap or net worth of 51.13 million. The enterprise value is 33.13 million.

Market Cap51.13M
Enterprise Value 33.13M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date Jul 30, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 83.41M
Shares Outstanding n/a
Shares Change (YoY) +10.10%
Shares Change (QoQ) +0.23%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 56.10M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 3.85
P/TBV Ratio 3.86
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.03
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.88

Financial Position

The company has a current ratio of 6.35, with a Debt / Equity ratio of 0.01.

Current Ratio 6.35
Quick Ratio 6.21
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.01
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -97.22% and return on invested capital (ROIC) is -104.31%.

Return on Equity (ROE) -97.22%
Return on Assets (ROA) -53.68%
Return on Invested Capital (ROIC) -104.31%
Return on Capital Employed (ROCE) -85.21%
Revenue Per Employee n/a
Profits Per Employee -456,280
Employee Count18
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -56.43% in the last 52 weeks. The beta is 1.72, so MDNAF's price volatility has been higher than the market average.

Beta (5Y) 1.72
52-Week Price Change -56.43%
50-Day Moving Average 0.67
200-Day Moving Average 0.95
Relative Strength Index (RSI) 44.28
Average Volume (20 Days) 28,158

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -14.20M
Pretax Income -8.21M
Net Income -8.21M
EBITDA -14.18M
EBIT -14.20M
Earnings Per Share (EPS) -0.11
Full Income Statement

Balance Sheet

The company has 17.28 million in cash and 116,882 in debt, giving a net cash position of 17.16 million.

Cash & Cash Equivalents 17.28M
Total Debt 116,882
Net Cash 17.16M
Net Cash Per Share n/a
Equity (Book Value) 13.28M
Book Value Per Share 0.17
Working Capital 16.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.47 million and capital expenditures -22,959, giving a free cash flow of -11.50 million.

Operating Cash Flow -11.47M
Capital Expenditures -22,959
Free Cash Flow -11.50M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MDNAF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.10%
Shareholder Yield n/a
Earnings Yield -16.06%
FCF Yield -22.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a